Publication:
The role of clinical pharmacist in evaluation of cardiometabolic risk and drug-related problems in patients with bipolar disorder

dc.contributor.authorYang, Seonyeong
dc.contributor.authorBingol-Ozakpinar, Ozlem
dc.contributor.authorNEBIOGLU, Melike
dc.contributor.authorCALISKAN, Mecit
dc.contributor.authorCIRAKLI, Zeynep
dc.contributor.authorMORISKY, Donald E.
dc.contributor.institutionauthorİZZETTİN, FIKRET VEHBI
dc.date.accessioned2020-10-29T20:54:37Z
dc.date.available2020-10-29T20:54:37Z
dc.identifier.citationYang S., OKUYAN B., SANCAR M., Bingol-Ozakpinar O., NEBIOGLU M., CALISKAN M., CIRAKLI Z., MORISKY D. E. , Izzettin F. V. , -The role of clinical pharmacist in evaluation of cardiometabolic risk and drug-related problems in patients with bipolar disorder-, INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, cilt.40, ss.273, 2018
dc.identifier.trdizintrdizin
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26175
dc.identifier.wosWOS:000426870000204
dc.titleThe role of clinical pharmacist in evaluation of cardiometabolic risk and drug-related problems in patients with bipolar disorder
dc.typeArticle
dspace.entity.typePublication
local.avesis.id7adc4894-b678-4ed0-b0ca-f5f3ffee103b
local.publication.isinternational1
relation.isAuthorOfPublicationcc4fb95b-daac-4065-9eea-9b57f6b44654
relation.isAuthorOfPublication.latestForDiscoverycc4fb95b-daac-4065-9eea-9b57f6b44654
Files